Linerixibat Long-term Safety, and Tolerability Study
Clinical trial NCT04167358 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04167358
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2026-09-30
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.